Keyphrases
Behavior Change
25%
Brain Regions
25%
Cannulated
25%
Central Nervous System
100%
Cerebellum
25%
Cortex
25%
Dopamine D2 Receptor (DRD2)
75%
Dopamine Receptor
25%
Dopaminergic Neurotransmission
100%
Dopaminergic System
25%
Drug Effects
25%
Glutamatergic System
25%
Grooming
25%
Locomotion
50%
Medial Prefrontal Cortex (mPFC)
25%
Microinjection
25%
N-methyl-D-aspartate
50%
N-methyl-D-aspartate Receptor (NMDAR)
100%
N-methyl-D-aspartate Receptor Antagonist
25%
Neurotransmission
25%
No Significant Difference
25%
Pathophysiology of Schizophrenia
25%
Phosphonic Acid
25%
Prefrontal Cortex
25%
Prefrontal Dopamine
25%
Propyl
25%
Quantitative PCR
25%
Receptor Activity
25%
Receptor Antagonism
25%
Receptor-mediated
100%
Sprague-Dawley Rats
25%
Striatal Dopamine
25%
Striatum
50%
Neuroscience
Aspartic Acid
100%
Behavior (Neuroscience)
16%
Central Nervous System
100%
Cerebellum
16%
Dopamine Receptor
16%
Dopamine Receptor D2
50%
Dopaminergic
16%
Locomotion
33%
Messenger RNA
50%
NMDA Receptor Antagonist
16%
Phosphonic Acids
16%
Prefrontal Cortex
33%
Receptor
100%
Reverse Transcription Polymerase Chain Reaction
16%
Striatum
33%
Synaptic Transmission
100%
Veterinary Science and Veterinary Medicine
Central Nervous System
100%
Cerebellum
50%
Corpus Striatum
100%
Dopaminergic
50%
Glutamatergic
50%
Prefrontal Cortex
100%
Protocerebrum
50%
Rat
50%
Pharmacology, Toxicology and Pharmaceutical Science
4 (3 Phosphonopropyl) 2 Piperazinecarboxylic Acid
16%
Aspartic Acid
100%
Dopamine Receptor
16%
Dopamine Receptor D2
50%
Dopamine Receptor Stimulating Agent
16%
Messenger RNA
50%
NMDA Receptor Antagonist
16%
Pathophysiology
16%
Receptor
100%
Sprague Dawley Rat
16%